Dr. Hönle AG

HNL

DE0005157101

Industrial Machinery & Equipment

Market Closed - Xetra Other stock markets 11:36:20 2024-05-28 am EDT			5-day change	1st Jan Change
19.85 ^EUR	-0.75%		-0.25%	+13.43%

May. 08	Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
Feb. 26	Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

DR HOENLE AG : Receives a Buy rating from Warburg Research

August 12, 2020 at 05:48 am EDT

Analyst Malte Schaumann from Warburg Research research considers the stock attractive and recommends it with a Buy rating. The target price is set at 64 versus 65 EUR.

Latest news about Dr. Hönle AG

Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 07	CI
Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 26	CI
Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2023	Jan. 24	CI
Dr. Hönle Ag Provides Earnings Guidance for the Year 2022/2023 and 2023/2024	Dec. 05	CI
Dr. Hönle AG Announces Management Changes	23-10-20	CI
Dr. Hönle AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-07	CI
Dr. Hönle Ag Provides Earnings Guidance for the Year 2023	23-08-07	CI
Dr. Hönle AG Revises Earnings Guidance for the Year 2022/ 2023	23-06-01	CI
Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-12	CI
Dr. Hönle AG Announces Executive Changes	23-04-25	CI
Dr. Hönle AG Announces Board Changes	23-03-31	CI
Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-24	CI
Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2022	23-01-30	CI
Dr. Hönle AG Announces Planned Change in Supervisory Board	22-12-15	CI
An unknown buyer acquired Raesch Quarz GmbH from Dr. Hönle AG.	22-12-11	CI
Dr. Hönle AG Revises Earnings Guidance for the Year 2021/2022	22-11-02	CI
Dr. Hönle AG(XTRA:HNL) dropped from S&P Global BMI Index	22-09-19	CI
Norbert Haimerl Becomes CEO of Dr. Hönle AG	22-08-23	CI
Dr. Hönle AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-05	CI
Dr. Hönle AG Provides Earnings Guidance for 2022	22-07-29	CI
Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-05-12	CI
Dr. Hönle Ag Provides Earnings Guidance for 2022	22-05-12	CI
Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2021	22-02-22	CI
Dr. Hönle AG Provides Earnings Guidance for the Financial Year 2021/2022	22-02-18	CI
Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2021	22-01-27	CI

Dr Hoenle AG is a Germany-based company engaged in the basic materials and industrials sectors. The Company develops, manufactures and supplies ultraviolet (UV) equipment. The Company operates three business segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment encompasses the development, production and sale of UV equipment and systems used for drying inks and coatings, for curing adhesives and plastics, disinfecting surfaces and for sunlight simulation. The Adhesives segment comprises the development, production and sale of UV industrial adhesives for the use in the automotive, electronics, medical technology and optics industries, among others. The Glass and Lamps segment includes the development, production and sale of tubing and semi-finished goods made from quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The Company is globally active, with over 69 locations in 27 countries.

Sector

Industrial Machinery & Equipment

Calendar

2024-08-06 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Dr. Hönle AG

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

19.85 EUR

Average target price

25.2 EUR

Spread / Average Target

+26.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Industrial Machinery & Equipment

	1st Jan change	Capi.
DR. HÖNLE AG	+13.43%	132M
ATLAS COPCO AB	+16.16%	89.26B
PARKER-HANNIFIN CORPORATION	+14.29%	68.1B
INGERSOLL RAND INC.	+20.84%	38.53B
SANDVIK AB	+8.44%	28.28B
FANUC CORPORATION	+9.24%	27.77B
FORTIVE CORPORATION	+1.26%	26.72B
DOVER CORPORATION	+19.29%	25.31B
TECHTRONIC INDUSTRIES CO. LTD.	+4.84%	23.28B
ALFA LAVAL AB	+19.88%	18.95B

Other Industrial Machinery & Equipment

Dr. Hönle AG

Equities

HNL

DE0005157101

Industrial Machinery & Equipment

DR HOENLE AG : Receives a Buy rating from Warburg Research

Latest news about Dr. Hönle AG

Chart Dr. Hönle AG

Company Profile

Income Statement Evolution

Ratings for Dr. Hönle AG

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Industrial Machinery & Equipment